---
category: news
title: "Kiromic BioPharma Reports First Quarter 2022 Financial Results and Recent Corporate Highlights"
excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) and data mining platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology,"
publishedDateTime: 2022-05-13T12:08:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-health-houston-artificial-intelligence-30ce6c45ac424dae9652f7c7d06dac34"
webUrl: "https://apnews.com/press-release/business-wire/technology-health-houston-artificial-intelligence-30ce6c45ac424dae9652f7c7d06dac34"
type: article
quality: 12
heat: 12
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Kiromic BioPharma Announces Company Will Directly Submit Amended IND for Procel™ to the FDA in Second Half of 2022"
    excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) and data mining platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology,"
    publishedDateTime: 2022-05-11T10:58:00Z
    webUrl: "https://apnews.com/press-release/business-wire/technology-health-houston-a68db34caf094793afed16ac7a1a9709"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 2
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true

secured: "t7hDR0PkNVepAzc0JNkN29xq0L5NtDCodODDJ5m9p2mBr/vC/pYV7aysSoT1vEeFe4xh2rsdzEVTk7auVFocHPz03hlrr4H+O2tugpyKtY2ORIASnVLHN7ADJs2wuEPUr2Qk1OlqTVLJgPeJvLyNwGGeWZiWFdcfTFFmGuLu+ARV4k3F64qDZ8kdPhv5tVvOoqfzNugzlBQW94k32EsbDByEwYnYNSBaSfyU0fvJaFLOb+Qe008wy0EsZBLFqZc3ylGc0of1xZBzOeIFK5Z8Qycj1AcaailfiFXUaLeWHHGPPmUiq1XHtU2oIeoveXrkp6wb3Yo50RSb3PARtRGeQyKZQHklfv+r33SvsNf8Ax0=;AogNiX0dmjwQ0PtpuWIR/A=="
---

